My post on ihub that will probably be deleted soon
Post# of 7769
It is not on the end of SCRC for the delay in selling rapimeds. The delay is in Hong Kong! You asked what about other regions. This has been answered on scrips' website on the business plan and the reason to go after the China market first. There is less competition and a need for genuine U.S products there. There is more upside there than trying to break into the U.S market where the competition is steep and already have a hold on the market share. SCRC also didn't have the funds it needed to enter the U.S market. I agree with Bob's decision to start with China.
Bob said there are other applications being developed for rapimeds. Would a company bother developing additional products in a pipeline if they had no intention or avenue to sell them? If the answer is yes then the same question can be asked as to why the same company has spent its own money in paying off notes early. It wouldn't if it's goal was to screw the shareholders and be deceitful.
There is a saying that patience is a virtue. I believe the patient will be rewarded.
Tomorrow will be the start of 2015! SCRC has a glorious 352 days for even more growth and production. In an interview Bob did back in November he stated he would like to get SCRC into manufacturing late 2015. There are many irons in the fire (PIMD WRX)and i'd like to remind all this company JUST became public in July of 2012. So in just 2.5 years this penny stock company has become profitible. What does one see in another year or two or three.....?
It's a no brainer for me and that's why I'm invested in SCRC.
(All my shares purchased and not one sold to date)
Happy New Year Mr. Schneiderman